Mechanisms of inherited cancer susceptibility.

Not All Next Generation Sequencing Diagnostics are Created Equal: Understanding the Nuances of Solid Tumor Assay Design for Somatic Mutation Detection. Cancers (Basel) (2015) 0.94

The significance of genetics for cholangiocarcinoma development. Ann Transl Med (2013) 0.78

TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy. Oncotarget (2016) 0.75

MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition. Cancer Biol Ther (2016) 0.75

Pancreatic cancer actionable genes in precision medicine and personalized surgery. Surgeon (2016) 0.75

Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A (1971) 31.05

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67

Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst (2002) 6.58

Clinical features and natural history of von Hippel-Lindau disease. Q J Med (1990) 4.71

Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science (1988) 4.54

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med (2001) 4.13

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst (1999) 3.26

Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet (2003) 3.24

Mutations associated with HNPCC predisposition -- Update of ICG-HNPCC/INSiGHT mutation database. Dis Markers (2004) 3.03

BRCA1: mechanisms of inactivation and implications for management of patients. Lancet (2002) 2.85

MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol (2001) 2.71

Genomic instability--the engine of tumorigenesis? Nat Rev Cancer (2003) 2.27

Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev (2002) 2.10

A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet (2004) 1.45

The tumor spectrum in the Lynch syndrome. Fam Cancer (2005) 1.27

The interactions of APC, E-cadherin and beta-catenin in tumour development and progression. J Pathol (1997) 1.27

Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study. Clin Cancer Res (2006) 1.18

Impact of screening examinations on survival in familial adenomatous polyposis. Scand J Gastroenterol (2000) 1.00

Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma. Cancer Res (1996) 0.92

Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancer. Gastroenterology (2004) 0.86

Prophylactic mastectomy in carriers of BRCA mutations. N Engl J Med (2001) 0.78